Hyun Min Kyung
Department of Preventive Medicine, College of Korean Medicine, Dongguk University, Gyeongju-si, Republic of Korea.
Evid Based Complement Alternat Med. 2016;2016:2625079. doi: 10.1155/2016/2625079. Epub 2016 Nov 23.
This study was conducted to compare the need for research and development (R&D) of Traditional Korean Medicine (TKM) perceived by the public and Traditional Korean Medicine doctor (KMD) in. Survey data from 2462 people and KMD were utilized for this study. Overall, 25.10% of the public and 90.91% of KMD answered that government grants for TKM R&D were "extremely necessary." The majority of respondents reported that grants were needed "for the advancement of science and technology in TKM" (public, 46.28%; KMD, 34.08%). Research regarding herbal medicine was the top priority of TKM R&D in both groups. However, "research facilities and training for researchers (27.85%)" was a close second priority of the public, but not KMD. Moreover, the public believed that safety from adverse effects and toxicity was a more important area of R&D in each discipline, but KMD did not find these to be important. The public and KMD generally agreed on the need for government grants for TKM R&D, but the public was more interested in safety than KMD. Therefore, government policy decision makers must consider opinions of both the public and KMD when planning government grants.
本研究旨在比较公众和韩医对韩医学研发需求的认知。本研究使用了来自2462名公众和韩医的调查数据。总体而言，25.10%的公众和90.91%的韩医回答说，政府对韩医学研发的资助“极其必要”。大多数受访者表示，资助是“为了韩医学的科技进步”所需要的（公众占46.28%；韩医占34.08%）。草药研究是两组中韩医学研发的首要任务。然而，“研究设施和研究人员培训（27.85%）”是公众的第二大优先事项，但韩医并非如此。此外，公众认为各学科中不良反应和毒性的安全性是研发中更重要的领域，但韩医并不认为这些很重要。公众和韩医普遍认同政府对韩医学研发资助的必要性，但公众比韩医更关注安全性。因此，政府政策决策者在规划政府资助时必须考虑公众和韩医双方的意见。
